Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh

At the beginning of the coronavirus disease 2019 (COVID-19) pandemic in Bangladesh, there was a scarcity of ideal biocontainment facilities to detect the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a risk group of 3 organisms. Molecular detection of SARS-CoV-2 must be performed in...

Full description

Saved in:
Bibliographic Details
Main Authors: SM Rashed Ul Islam, Tahmina Akther, Sharmin Sultana, Paroma Deb, Asish Kumar Ghosh, Md. Abdullah Omar Nasif, Amirul Huda Bhuiyan, Munira Jahan, Afzalun Nessa, Saif Ullah Munshi, Shahina Tabassum
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2021-12-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/14415
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850148248910561280
author SM Rashed Ul Islam
Tahmina Akther
Sharmin Sultana
Paroma Deb
Asish Kumar Ghosh
Md. Abdullah Omar Nasif
Amirul Huda Bhuiyan
Munira Jahan
Afzalun Nessa
Saif Ullah Munshi
Shahina Tabassum
author_facet SM Rashed Ul Islam
Tahmina Akther
Sharmin Sultana
Paroma Deb
Asish Kumar Ghosh
Md. Abdullah Omar Nasif
Amirul Huda Bhuiyan
Munira Jahan
Afzalun Nessa
Saif Ullah Munshi
Shahina Tabassum
author_sort SM Rashed Ul Islam
collection DOAJ
description At the beginning of the coronavirus disease 2019 (COVID-19) pandemic in Bangladesh, there was a scarcity of ideal biocontainment facilities to detect the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a risk group of 3 organisms. Molecular detection of SARS-CoV-2 must be performed in a BSL-2 laboratory with BSL-3-equivalent infection prevention and control practices. Establishing these facilities within a short timeframe proved to be an enormous challenge, including locating a remote space distant from the university campus to establish a laboratory, motivating the laboratory staff to work with a novel pathogen without any prior experience, allocation of funds for essential equipment and accessories, and arrangement of a safe waste management system for environmental hazard reduction. This report also highlights several limitations, such as the facility's architectural design that did not follow the biosafety guidelines, lack of continuous flow of funds, and an inadequate number of laboratory personnel. This article describes various efforts taken to overcome the challenges during the establishment of this facility that may be adopted to create similar facilities in other regions of the country. Establishing a BSL-2 laboratory with BSL-3-equivalent infection prevention and control practices will aid in the early detection of a large number of cases, thereby isolating persons with COVID-19, limiting the transmission of SARS-CoV-2, and promoting a robust public health response to contain the pandemic.
format Article
id doaj-art-a007931fd1534cb6ad4e9db99aef51c6
institution OA Journals
issn 1972-2680
language English
publishDate 2021-12-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-a007931fd1534cb6ad4e9db99aef51c62025-08-20T02:27:18ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802021-12-01151210.3855/jidc.14415Challenges in the establishment of a biosafety testing laboratory for COVID-19 in BangladeshSM Rashed Ul Islam0Tahmina Akther1Sharmin Sultana2Paroma Deb3Asish Kumar Ghosh4Md. Abdullah Omar Nasif5Amirul Huda Bhuiyan6Munira Jahan7Afzalun Nessa8Saif Ullah Munshi9Shahina Tabassum10Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, BangladeshDepartment of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, BangladeshDepartment of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, BangladeshDepartment of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, BangladeshDepartment of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, BangladeshDepartment of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, BangladeshDepartment of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, BangladeshDepartment of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, BangladeshDepartment of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, BangladeshDepartment of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, BangladeshDepartment of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, Bangladesh At the beginning of the coronavirus disease 2019 (COVID-19) pandemic in Bangladesh, there was a scarcity of ideal biocontainment facilities to detect the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a risk group of 3 organisms. Molecular detection of SARS-CoV-2 must be performed in a BSL-2 laboratory with BSL-3-equivalent infection prevention and control practices. Establishing these facilities within a short timeframe proved to be an enormous challenge, including locating a remote space distant from the university campus to establish a laboratory, motivating the laboratory staff to work with a novel pathogen without any prior experience, allocation of funds for essential equipment and accessories, and arrangement of a safe waste management system for environmental hazard reduction. This report also highlights several limitations, such as the facility's architectural design that did not follow the biosafety guidelines, lack of continuous flow of funds, and an inadequate number of laboratory personnel. This article describes various efforts taken to overcome the challenges during the establishment of this facility that may be adopted to create similar facilities in other regions of the country. Establishing a BSL-2 laboratory with BSL-3-equivalent infection prevention and control practices will aid in the early detection of a large number of cases, thereby isolating persons with COVID-19, limiting the transmission of SARS-CoV-2, and promoting a robust public health response to contain the pandemic. https://jidc.org/index.php/journal/article/view/14415COVID-19SARS-CoV-2Biosafety laboratorychallenges
spellingShingle SM Rashed Ul Islam
Tahmina Akther
Sharmin Sultana
Paroma Deb
Asish Kumar Ghosh
Md. Abdullah Omar Nasif
Amirul Huda Bhuiyan
Munira Jahan
Afzalun Nessa
Saif Ullah Munshi
Shahina Tabassum
Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh
Journal of Infection in Developing Countries
COVID-19
SARS-CoV-2
Biosafety laboratory
challenges
title Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh
title_full Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh
title_fullStr Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh
title_full_unstemmed Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh
title_short Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh
title_sort challenges in the establishment of a biosafety testing laboratory for covid 19 in bangladesh
topic COVID-19
SARS-CoV-2
Biosafety laboratory
challenges
url https://jidc.org/index.php/journal/article/view/14415
work_keys_str_mv AT smrashedulislam challengesintheestablishmentofabiosafetytestinglaboratoryforcovid19inbangladesh
AT tahminaakther challengesintheestablishmentofabiosafetytestinglaboratoryforcovid19inbangladesh
AT sharminsultana challengesintheestablishmentofabiosafetytestinglaboratoryforcovid19inbangladesh
AT paromadeb challengesintheestablishmentofabiosafetytestinglaboratoryforcovid19inbangladesh
AT asishkumarghosh challengesintheestablishmentofabiosafetytestinglaboratoryforcovid19inbangladesh
AT mdabdullahomarnasif challengesintheestablishmentofabiosafetytestinglaboratoryforcovid19inbangladesh
AT amirulhudabhuiyan challengesintheestablishmentofabiosafetytestinglaboratoryforcovid19inbangladesh
AT munirajahan challengesintheestablishmentofabiosafetytestinglaboratoryforcovid19inbangladesh
AT afzalunnessa challengesintheestablishmentofabiosafetytestinglaboratoryforcovid19inbangladesh
AT saifullahmunshi challengesintheestablishmentofabiosafetytestinglaboratoryforcovid19inbangladesh
AT shahinatabassum challengesintheestablishmentofabiosafetytestinglaboratoryforcovid19inbangladesh